Literature DB >> 24260734

Recurrent intradialytic heparin induced anaphylaxis: workup and management.

Amelia Santosa1, Seng Hoe Tan, Yew Kuang Cheng.   

Abstract

Heparin has been widely used for intradialytic anticoagulation since the 1940s. Heparin induced anaphylaxis can be life threatening, mandating early recognition and intervention. However, due to its relative rarity many physicians remain unaware. We report the case of a 70-year-old woman requiring dialysis, who developed recurrent anaphylaxis to intradialytic heparin. We describe a systematic approach to confirm the suspected heparin allergy, which must include an evaluation of predisposing factors, the dialysis equipment and concomitant medications. Further workup for safe alternatives employing skin prick and intradermal tests, as well as provocation tests are discussed.

Entities:  

Keywords:  Anaphylaxis; Dialysis; Drug hypersensitivity; Heparin; Intradermal test; Skin tests

Year:  2013        PMID: 24260734      PMCID: PMC3826609          DOI: 10.5415/apallergy.2013.3.4.285

Source DB:  PubMed          Journal:  Asia Pac Allergy        ISSN: 2233-8276


  14 in total

1.  Anaphylactoid reaction induced by low-molecular-weight heparin in a hemodialysis patient.

Authors:  A Ueda; S Nagase; N Morito; M Yotsumoto; S Ohba; Y Hasegawa; M Narita; A Koyama
Journal:  Nephron       Date:  2001-01       Impact factor: 2.847

Review 2.  [Allergy to heparin, heparinoids, and recombinant hirudin. Diagnostic and therapeutic alternatives].

Authors:  U Jappe; H Gollnick
Journal:  Hautarzt       Date:  1999-06       Impact factor: 0.751

3.  Bradykinin and nitric oxide generation by dialysis membranes can be blunted by alkaline rinsing solutions.

Authors:  R Coppo; A Amore; P Cirina; B Scelfo; F Giacchino; L Comune; M Atti; J L Renaux
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

Review 4.  The complex clinical picture of side effects to anticoagulation.

Authors:  Axel Trautmann; Cornelia S Seitz
Journal:  Med Clin North Am       Date:  2010-07       Impact factor: 5.456

Review 5.  Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options.

Authors:  A J Bircher; T Harr; L Hohenstein; D A Tsakiris
Journal:  Allergy       Date:  2006-12       Impact factor: 13.146

6.  Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper.

Authors:  K Brockow; L H Garvey; W Aberer; M Atanaskovic-Markovic; A Barbaud; M B Bilo; A Bircher; M Blanca; B Bonadonna; P Campi; E Castro; J R Cernadas; A M Chiriac; P Demoly; M Grosber; J Gooi; C Lombardo; P M Mertes; H Mosbech; S Nasser; M Pagani; J Ring; A Romano; K Scherer; B Schnyder; S Testi; M Torres; A Trautmann; I Terreehorst
Journal:  Allergy       Date:  2013-04-25       Impact factor: 13.146

7.  Gordon Murray: heparin, hemodialysis and hubris.

Authors:  Susan K Fellner; Mabel L Purkerson
Journal:  Am J Nephrol       Date:  2002-07       Impact factor: 3.754

Review 8.  Successful heparin desensitization: a case report and review of the literature.

Authors:  Shoban Dave; Miguel A Park
Journal:  J Card Surg       Date:  2008 Jul-Aug       Impact factor: 1.620

9.  Successful desensitization with un-fractionated heparin in a patient with heparin allergy and tolerance to fondaparinux.

Authors:  Ayse Baccioglu Kavut; Ebru Koca
Journal:  Asian Pac J Allergy Immunol       Date:  2012-06       Impact factor: 2.310

10.  Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes.

Authors:  L Verresen; E Fink; H D Lemke; Y Vanrenterghem
Journal:  Kidney Int       Date:  1994-05       Impact factor: 10.612

View more
  2 in total

Review 1.  Practical Management of Patients with a History of Immediate Hypersensitivity to Common non-Beta-Lactam Drugs.

Authors:  Eric Macy
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 2.  Diagnosis, Treatment, and Prevention of Hemodialysis Emergencies.

Authors:  Manish Saha; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-09       Impact factor: 8.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.